Important note: Information in this article was accurate in 2006. The state of the art may have changed since the publication date.
Important note: Information in this article was accurate in 2006. The state of the art may have changed since the publication date.
Reuters NewMedia - December 5, 2006
Zimbabwe is among the countries worst hit by the HIV/AIDS pandemic, which kills more than 3,000 people every week and accounts for 70 percent of hospital admissions.
But the crisis-hit southern African nation has also become one of the continent's few AIDS bright spots after its HIV prevalence rate declined to 18.1 percent this year from 25 percent five years ago.
Despite this, UNICEF said the number of children orphaned by AIDS continued to rise.
"Almost one in four children in Zimbabwe, 1.6 million, are now orphaned, having lost at least one parent, and this number is growing," UNICEF Zimbabwe representative Festo Kavishe said in a statement sent to Reuters on Tuesday.
"HIV and AIDS have dramatically increased children's vulnerability in recent years to the point where Zimbabwe now has the highest percentage of children who are orphans in the world," Kavishe added.
Last week President Robert Mugabe said Zimbabwe's declining HIV/AIDS prevalence rate showed it was showing the way for Africa in the fight against the scourge.
Health experts attribute the drop to more condom use and the success of programmes encouraging people to have fewer sexual partners.
UNICEF said it had received $6 million from Sweden, which would be used to increase school enrolment of orphans and vulnerable children, boost school nutrition programmes and reduce the number of children living outside families.
Zimbabwe continued to lead in the care of the orphans and vulnerable children despite a severe economic crisis, with 90 percent of the country's orphans having been absorbed by the extended family, UNICEF said.
061205
RE061214
Copyright © 2006 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2006. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2006. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .